The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1428
Belotero Balance for Wrinkles and Folds
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Belotero Balance (Merz), an injectable hyaluronic acid dermal filler, has been approved by the FDA for temporary correction of moderate-to-severe facial wrinkles and folds. Several other hyaluronic acid products are also available for this indication (e.g., Restylane, Perlane, Juvéderm).1 They have supplanted bovine collagen products, which persist for a shorter time and cause more allergic reactions.

MECHANISM OF ACTION — Cross-linked hyaluronic acid products bind to water, preserving the volume of the injected material until all the hyaluronic acid has been degraded by naturally occurring hyaluronidases. They may also stimulate collagen production.2 In the case of overcorrection or excess fullness, an injection of hyaluronidase can reverse the effects.

CLINICAL STUDIES — Approval of Belotero ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Belotero Balance for Wrinkles and Folds
Article code: 1428b
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian